Global Neurological Biomarkers Market Research Report, Competitive, Technology and Forecast Analysis 2025-2032

Market Overview

According to DIResearch's in-depth investigation and research, the global Neurological Biomarkers market size will reach 10,610 Million USD in 2025 and is projected to reach 26,191 Million USD by 2032, with a CAGR of 13.78% (2025-2032). Notably, the China Neurological Biomarkers market has changed rapidly in the past few years. By 2025, China's market size is expected to be Million USD, representing approximately % of the global market share.

Research Summary

Neurological biomarkers are measurable indicators or characteristics that provide information about the state or function of the nervous system. These biomarkers can include various physiological, biochemical, or imaging-based measurements that are associated with normal neurological function or specific neurological conditions or diseases. Examples of neurological biomarkers include specific proteins or molecules found in cerebrospinal fluid or blood, abnormalities or patterns observed in brain imaging scans (such as magnetic resonance imaging or positron emission tomography), and electrical activity recorded from the brain (such as electroencephalography). Neurological biomarkers can help in the diagnosis, prognosis, and monitoring of neurological disorders, as well as in the development and evaluation of new treatments and interventions. They serve as objective measures that complement clinical assessments, aiding in the understanding of disease progression, response to therapy, and the identification of potential therapeutic targets.

The major global  manufacturers of Neurological Biomarkers include Thermo Fisher Scientific, Merck, Quest Diagnostics, Roche, Abbott, QIAGEN, Bio-Rad Laboratories, Illumina, Cisbio Bioassays, Myriad RBM, Athena Diagnostics, BGI, Wuxi APP, Aepodia, Proteome Sciences, Genewiz, etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.

This report studies the market size, price trends and future development prospects of Neurological Biomarkers. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Neurological Biomarkers market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.

The regions and countries in the report include US, Germany, Japan, China, France, UK, South Korea, Canada, Italy, Russia, Mexico, Brazil, India, Vietnam, Thailand, South Africa and other regions, covering the Neurological Biomarkers market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Neurological Biomarkers industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.    

The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.

Global Key Manufacturers of Neurological Biomarkers Include:

Thermo Fisher Scientific

Merck

Quest Diagnostics

Roche

Abbott

QIAGEN

Bio-Rad Laboratories

Illumina

Cisbio Bioassays

Myriad RBM

Athena Diagnostics

BGI

Wuxi APP

Aepodia

Proteome Sciences

Genewiz

Neurological Biomarkers Product Segment Include:

Proteomics

Genomics

Imaging

Bioinformatics

Others

Neurological Biomarkers Product Application Include:

Diagnostics

Drug Discovery

Personalized Medicine

Others

Chapter Scope

Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trend

Chapter 2: Global Neurological Biomarkers Industry PESTEL Analysis

Chapter 3: Global Neurological Biomarkers Industry Porter's Five Forces Analysis

Chapter 4: Global Neurological Biomarkers Major Regional Market Size (Sales, Revenue, Price) and Forecast Analysis

Chapter 5: Global Neurological Biomarkers Competitive Analysis of Key Manufacturers (Sales, Revenue, Market Share, Price, Regional Distribution and Industry Concentration)

Chapter 6: Global Neurological Biomarkers Sales, Revenue, Price and Forecast by Product Type

Chapter 7: Key Company Profiles (Product Portfolio, Sales, Revenue, Price and Gross Margin)

Chapter 8: Industrial Chain Analysis, Neurological Biomarkers Different Application Market Analysis (Sales and Revenue), Sales Channel Analysis

Chapter 9: Research Findings and Conclusion

Chapter 10: Methodology and Data Sources